Jonathan Silva

Jonathan Silva is a Professor in the Department of Biomedical Engineering at Washington University in St. Louis. He joined the faculty in July 2012 following the receipt of the Burroughs Wellcome Fund Career Award at the Scientific Interface (CASI). His affiliations include the Cardiac Bioelectricity & Arrhythmia Center (CBAC), the Center for Science and Engineering of Living Systems, and the Division of Biology & Biomedical Sciences.

Professor Silva holds the following educational qualifications:

• PhD, Washington University in St. Louis, 2008
• MS, Case Western Reserve University, 2004
• BS, Johns Hopkins University, 2000

His research interests encompass cardiovascular engineering, cell and molecular bioengineering, computational systems biology, and regenerative engineering in medicine. Silva’s work emphasizes improving cardiac arrhythmia therapies through advanced imaging techniques and machine learning algorithms. He also pioneers the use of computational models and extended reality (XR) technologies, such as holographic displays that assist physicians during catheter ablation procedures. These innovations have been validated in human trials, showcasing their clinical utility.

In terms of scientific awards, Silva has received:

• Burroughs Wellcome Fund Career Award at the Scientific Interface (CASI)

While no formal advisees are listed, Silva’s research lab contributes significantly to translational medicine and technology commercialization. His work with SentiAR Inc exemplifies this, as the company is commercializing his lab’s holographic software. He has also been recognized for patents and entrepreneurial achievements, as noted in university news releases.

Silva’s laboratory is situated in Whitaker Hall, Rooms 250 and 260. The lab collaborates with multiple centers to advance cardiac bioelectricity studies, systems biology, and innovative medical technologies. His interdisciplinary approach bridges computational methods with clinical applications, aiming to revolutionize cardiac care through precision therapies and augmented reality tools.